vTv Therapeutics (VTVT) Notes Payables (2017 - 2025)
vTv Therapeutics (VTVT) has disclosed Notes Payables for 10 consecutive years, with $328000.0 as the latest value for Q3 2025.
- Quarterly Notes Payables changed N/A to $328000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $328000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $191000.0 for FY2023, 14.73% down from the prior year.
- Notes Payables hit $328000.0 in Q3 2025 for vTv Therapeutics, up from $191000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $636000.0 in Q3 2021 to a low of $191000.0 in Q4 2023.
- Historically, Notes Payables has averaged $380714.3 across 4 years, with a median of $328000.0 in 2025.
- Biggest YoY gain for Notes Payables was 204.76% in 2021; the steepest drop was 73.15% in 2021.
- Year by year, Notes Payables stood at $256000.0 in 2021, then dropped by 12.5% to $224000.0 in 2022, then fell by 14.73% to $191000.0 in 2023, then surged by 71.73% to $328000.0 in 2025.
- Business Quant data shows Notes Payables for VTVT at $328000.0 in Q3 2025, $191000.0 in Q4 2023, and $473000.0 in Q3 2023.